Depression in Palliative Care Patients

REFERENCES

• Goldberg R J. Management of depression in the patient with advanced cancer. JAMA. 1981; 246: 373–6
   PubMed Web of Science ®Google Scholar
• Barraclough J. ABC of palliative care: depression, anxiety, and confusion. BMJ. 1997; 315: 1365–8
   PubMedGoogle Scholar
• Breitbart W. Identifying patients at risk for, and treatment of major psychiatric complications of cancer. Support Care Cancer. 1995; 3: 45–60
   PubMed Web of Science ®Google Scholar
• Minagawa H, Uchitomi Y, Yamawaki S, Ishitani K. Psychiatric morbidity in terminally ill cancer patients. Cancer. 1996; 78: 1131–7
   PubMed Web of Science ®Google Scholar
• Chochinov H M, Wilson K G, Enns M, Landers S. Prevalence of depression in the terminally ill: effects of diagnostic criteria and symptom threshold judgments. Am J Psychiatry. 1994; 151: 537–40
   PubMed Web of Science ®Google Scholar
• Andrykowski M A, Curran S L, Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behavior Med. 1998; 21: 1–17
   PubMed Web of Science ®Google Scholar
• Massie J M, Popkin M K. Depressive disorders. Psycho-oncology, J C Holland. Oxford University Press;, New York 1998; 518–40
   Google Scholar
• Breitbart W, Passik S D. Psychiatric aspects of palliative care. Oxford Textbook of Palliative Medicine, D Doyle, G WC Hanks, N MacDonald. Oxford University Press;, New York 1993; 609–26
   Google Scholar
• Breitbart W, Jacobsen P B. Psychiatric symptom management in terminal care. Clin Geriatr Med. 1996; 12: 329–347
   Google Scholar
• Anon. Some drugs that cause psychiatric symptoms. Med Lett. 1998; 40: 20–4
   Google Scholar
• Chochinov H M, Wilson K G, Enns M, Lander S. “Are you depressed?” Screening for depression in the terminally ill. Am. J. Psychiatry. 1997; 154: 674–6
   Google Scholar
• Zigmond A S, Snaith R P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67: 361–70
   PubMed Web of Science ®Google Scholar
• Cramond W A. Psychotherapy of the dying patient. BMJ. 1970; 3: 389–93
   PubMedGoogle Scholar
• Wood B C, Mynors-Wallis L M. Problem-solving therapy in palliative care. Palliat Med. 1997; 11: 49–54
   Google Scholar
• Bidder T G. Electroconvulsive therapy in the medically ill patient. Psychiatric Clinics of North America. 1981; 4: 391–405
   PubMed Web of Science ®Google Scholar
• Breitbart W, Jacobsen P B. Psychiatric symptom management in terminal care. Clin Geritr Med. 1996; 12: 329–47
   Google Scholar
• Breitbart W, Bruera E, Chochinov H, Lynch M. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage. 1995; 10: 131–41
   PubMed Web of Science ®Google Scholar
• Kinzel T. Relief of emotional symptoms in elderly patients with terminal cancer. Geriatrics. 1988; 43: 61–5, 68
   Google Scholar
• Roth A J, Breitbart W. Psychiatric emergencies in terminally ill cancer patients. Hematol Oncol Clin North Am. 1996; 10: 235–59
   Google Scholar
• Holmes V F. Medical use of psychostimulants: an overview. Int J Psychiatry Med. 1995; 25: 1–19
   PubMed Web of Science ®Google Scholar
• Yee J D, Berde C B. Dextroamphetamine or methylphenidate as adjuvants to opioid analgesia for adolescents with cancer. J Pain Symptom Manage. 1994; 9: 122–5
   PubMedGoogle Scholar
• Roth A J, Breitbart W. Psychiatric emergencies in terminally ill cancer patients. Pain and Palliat Care. 1996; 10: 235–59
   Google Scholar
• Rudorfer M V, Manji H K, Potter W Z. Comparative tolerability profiles of the newer versus older antidepressants. Drug Saf. 1994; 10: 18–46
   PubMed Web of Science ®Google Scholar
• Chaumeil J C, Khoury J M, Zuber M, et al. Formulation of suppositories containing imipramine and clomipramine chlorhydrates. Drug Dev Indust Pharm. 1988; 14: 2225–39
   Web of Science ®Google Scholar
• Adams F. Amitriptyline suppositories. N Engl J Med 1982; 306: 996
   Google Scholar
• Cohen S R. Phototherapy in the treatment of depression in the terminally ill. Symptom Manage. 1994; 9: 534–6
   Google Scholar
• Johnston B. Relief of mixed anxiety-depression in terminal cancer patients: effect of thioridazine. New York State J Med. 1972; 73: 2315–17
   Google Scholar
• Maisami M, Sohmer B H, Coyle J T. Combined use of tricyclic antidepressants and neuroleptics in the management of terminally ill children: a report on three cases. J Amer Academy Child Psychiatry. 1985; 24: 487–9
   Google Scholar
• Sheehan M K, Janicak P G, Dowd S. The role of psychopharmacotherapy in the dying patient. Psychiatric Annals. 1994; 24: 98–103
   Google Scholar
• Malitz S, Goldstein E. Psychotherapy and pharmacotherapy in a dying patient: report of a supervised case. J Thanatol. 1972; 2: 744–56
   Google Scholar
• Macleod A D. Methylphenidate in terminal depression. J Pain Symptom Manage. 1998; 16: 193–8
   PubMed Web of Science ®Google Scholar
• Breitbart W, Mermelstein H. Pemoline: an alternative psychostimulant for the management of depressive disorders in cancer patients. Psychosomatics. 1992; 33: 352–6
   PubMed Web of Science ®Google Scholar